A generic alternative indicated for Oncology Support. Facilitates the inhibition of androgen biosynthesis to manage prostate cell reproduction effectively.
Formulated to target cancer cell growth by stopping hormone production to address advanced prostate conditions and mitigate disease progression.
Mechanism of Action
This medication inhibits the enzyme CYP17, which is necessary for the body to produce androgens (male hormones). By reducing these hormone levels in the testes and the tumor itself, it slows the growth of hormone-sensitive cancer cells.
Route of Administration
Oral
Onset Time
Variable; blood levels peak in 2 hours
Duration
24 hours
Contraindications
Severe liver impairment, Pregnancy or women of childbearing age, Hypersensitivity to abiraterone
Severe Adverse Events
Severe liver toxicity, Adrenal insufficiency, Heart rhythm problems, Severe potassium loss
Common Side Effects
Hot flashes, Joint swelling
Uncommon Side Effects
Muscle aches, Diarrhea, Fluid retention, High blood pressure
Drug Interactions
Rifampin, Phenytoin, Carbamazepine, St. John's Wort, Ketoconazole
Pregnancy Safety Warnings
Contraindicated; can cause fetal harm.
Age Restrictions
Not for use in children.
Storage Guidelines
Store at room temperature in the original container.
Information for Abiraterone is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
